CoreRx Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CoreRx Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10552
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CoreRx Inc (CoreRx) is a contract development manufacturing organization that provides a comprehensive range of drug development services. The company provides products portfolio such as oral, topical, liquids or parental, ophthalmic and combined medicines, among others. It provides a wide range of drug product development services for manufacturing and testing of solid, liquid and semi-solid dosage forms, among others. CoreRx provides services such as formulation development, analytical and clinical material manufacturing solutions. It provides topical products in various dosage forms including gels, creams, ointments, lotions, capsules, tablets, thin film strips, suspensions, injectables, and others. The company caters pharmaceutical and biotechnology industries. CoreRx is headquartered in Clearwater, Florida, the US.

CoreRx Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CoreRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CoreRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CoreRx Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CoreRx Raises USD5 Million in Venture Financing 10
CoreRx Raises USD7 Million in Venture Financing 11
Partnerships 12
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 12
Equity Offering 13
CoreRx Raises Funds in Private Placement of Shares 13
CoreRx Inc – Key Competitors 14
CoreRx Inc – Key Employees 15
CoreRx Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Strategy And Business Planning 17
Jun 07, 2017: CoreRx and Aimmune Therapeutics Joint Expansion to Create Pharmaceutical Jobs and Increase the Base of Scientific Capabilities in the Tampa Bay Area 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
CoreRx Inc, Pharmaceuticals & Healthcare, Key Facts 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CoreRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CoreRx Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CoreRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CoreRx Raises USD5 Million in Venture Financing 10
CoreRx Raises USD7 Million in Venture Financing 11
TesoRx And CoreRx Form Joint Venture For Oral Testosterone Drug 12
CoreRx Raises Funds in Private Placement of Shares 13
CoreRx Inc, Key Competitors 14
CoreRx Inc, Key Employees 15

List of Figures
CoreRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CoreRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CoreRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CoreRx Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Outotec Oyj:企業のM&A・事業提携・投資動向
    Outotec Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Outotec Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Fossil Group, Inc.:企業の戦略・SWOT・財務情報
    Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • United Services Automobile Association:企業のM&A・事業提携・投資動向
    United Services Automobile Association - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Services Automobile Association Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Daidalos Solutions BV:企業の製品パイプライン分析2018
    Summary Daidalos Solutions BV (Daidalos Solutions) is a medical device company. The company offers products such as sutureless biological heart valve prostheses, sutureless mechanical heart valve prostheses, sutureless heart valve repair rings, sutureless working channels and ports, sutureless closi …
  • KPMG International Coop:企業の戦略的SWOT分析
    KPMG International Coop - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Nationwide Building Society:企業の戦略・SWOT・財務情報
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Trellis Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trellis Bioscience Inc (Trellis) is a drug development company that discovers and develops human antibody therapeutics for the treatment of bacterial and viral infectious diseases and cancer indications. The company’s clinical candidate includes TRL1068, which targets and disintegrates bacte …
  • Curemark LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drug candidates. Its drug candidate CM-AT is a clinical trial for autism, ADHD, …
  • Boston Children’s Hospital-医療機器分野:企業M&A・提携分析
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Bastide Le Confort Medical SA (BLC)-医療機器分野:企業M&A・提携分析
    Summary Bastide Le Confort Medical SA (Bastide Le) is a medical equipment company that provides personal care products. The company offers medical devices for individuals and home health care professionals. It provides products such as lift chairs and accessories, pillows, cushions and special seati …
  • OMV Petrom SA (SNP):石油・ガス:M&Aディール及び事業提携情報
    Summary OMV Petrom SA (Petrom), a subsidiary of OMV AG, is an integrated energy company that explores for, develops and produces crude oil and natural gas. The company processes and refines crude oil and sells refined products. It conducts power generation and has considerable wind energy operations …
  • CNP Assurances SA:企業の戦略・SWOT・財務情報
    CNP Assurances SA - Strategy, SWOT and Corporate Finance Report Summary CNP Assurances SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Citic Resources Holdings Limited:企業の戦略・SWOT・財務分析
    Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Citic Resources Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Denso Corporation (6902):企業の財務・戦略的SWOT分析
    Denso Corporation (6902) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lilis Energy Inc (LLEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Lilis Energy Inc (Lilis Energy), formerly Recovery Energy Inc is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in the Permian's Delaware Basin. The company identifies drilling locations for multi-horizon un …
  • Coastal Contacts Inc-医療機器分野:企業M&A・提携分析
    Summary Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International is an online retailer that markets eye care products. The company's products include eyeglasses, contact lenses, sunglasses, vision care accessories, and others. Its contact lenses comprise daily wear colour lense …
  • Aragen Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process de …
  • University of British Columbia-製薬・医療分野:企業M&A・提携分析
    Summary University of British Columbia (UBC) is a research institute that offers educational services. The university provides undergraduate, graduate educational programs, and research programs through its schools and faculties. It provides cultural, recreational and social activities for its stude …
  • Meridian Energy Ltd (MEL):企業の財務・戦略的SWOT分析
    Meridian Energy Ltd (MEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • miacom diagnostics GmbH-医療機器分野:企業M&A・提携分析
    Summary miacom diagnostics GmbH (miacom) is a molecular diagnostic company that develops and distributes molecular diagnostic tests. The company offers products such as hemoFISH, which identifies sepsis-related pathogens directly from positive blood culture bottles; respiFISH that identifies pathoge …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆